Outcomes of Patients with Large B-Cell Lymphomas and Progressive Disease Following CD19-Specific CAR T-Cell Therapy

被引：6
|
作者：
Chow, Victor A. [1 ,2 ,3 ]
Gopal, Ajay K. [2 ,4 ,5 ]
Maloney, David G. [1 ,2 ,5 ]
Turtle, Cameron J. [1 ,2 ,5 ]
Smith, Stephen D. [1 ,2 ,6 ]
Shadman, Mazyar [1 ,2 ,5 ]
Cassaday, Ryan D. [1 ,2 ,5 ]
Till, Brian G. [1 ,2 ,3 ]
Tseng, Yolanda D. [2 ,7 ]
Warren, Edus H. [2 ,3 ,8 ]
Shustov, Andrei R. [1 ,2 ,9 ]
Menon, Manoj P. [1 ]
Kanan, Sandra [2 ]
Acharya, Utkarsh H. [1 ,2 ,5 ,10 ]
Mullane, Erin [2 ]
Hannan, Lindsay M. [1 ,2 ,3 ]
Voutsinas, Jenna M. [8 ]
Gooley, Ted [1 ]
Lynch, Ryan C. [2 ,3 ,4 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[2] Seattle Canc Care Alliance, Seattle, WA USA
[3] Univ Washington, Dept Med, Div Med Oncol, Seattle, WA USA
[4] Univ Washington, Fred Hutchinson Canc Res Ctr, Seattle, WA 98195 USA
[5] Univ Washington, Dept Med, Seattle, WA USA
[6] Univ Washington, Seattle Canc Care Alliance, Seattle, WA 98195 USA
[7] Univ Washington, Dept Radiat Oncol, Seattle, WA 98195 USA
[8] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA
[9] Univ Washington, Seattle, WA 98195 USA
[10] Brigham & Womens Hosp, Dana Farber Canc Inst, Med Oncol, 75 Francis St, Boston, MA 02115 USA
来源：
BLOOD | 2018年 / 132卷
关键词：
D O I：
10.1182/blood-2018-99-110747
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
94
引用
收藏
页数：4
相关论文
共 50 条
  • [1] Outcomes of Patients With Large B-Cell Lymphomas and Progressive Disease Following CD19-Specific CAR T-Cell Therapy
    不详
    CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2019, 17 (05) : 19 - 20
  • [2] Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapy
    Chow, Victor A.
    Gopal, Ajay K.
    Maloney, David G.
    Turtle, Cameron J.
    Smith, Stephen D.
    Ujjani, Chaitra S.
    Shadman, Mazyar
    Cassaday, Ryan D.
    Till, Brian G.
    Tseng, Yolanda D.
    Warren, Edus H.
    Shustov, Andrei R.
    Menon, Manoj P.
    Bhark, Sandra
    Acharya, Utkarsh H.
    Mullane, Erin
    Hannan, Lindsay M.
    Voutsinas, Jenna M.
    Gooley, Ted A.
    Lynch, Ryan C.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 (08) : E209 - E213
  • [3] Statins May Improve Outcomes and Toxicities in Patients Undergoing CD19-Specific CAR T-Cell Therapy for Aggressive B-Cell Lymphomas
    Adroja, Shubham
    Burns, Ethan A.
    Giese, Noah
    Mathur, Sunil
    Khosla, Meera
    Rios, Jacqueline
    Hassanain, Hala S.
    Lulla, Premal D.
    Ramos, Carlos A.
    Yuen, Carrie
    Tang, Chih-Hang Anthony
    Hu, Chih-Chi Andrew
    Ganguly, Siddhartha
    Heslop, Helen Elisabeth
    Pingali, Sai Ravi Kiran
    BLOOD, 2024, 144 : 5131 - 5132
  • [4] Impact of Lab Abnormalities at the Time of Progression in Patients Receiving CD19-Specific CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas
    Lynch, Ryan C.
    Chow, Victor A.
    Maloney, David G.
    Turtle, Cameron J.
    Smith, Stephen D.
    Shadman, Mazyar
    Ujjani, Chaitra S.
    Cassaday, Ryan D.
    Till, Brian G.
    Tseng, Yolanda D.
    Warren, Edus H.
    Shustov, Andrei R.
    Menon, Manoj P.
    Voutsinas, Jenna M.
    Gooley, Ted
    Gopal, Ajay K.
    BLOOD, 2019, 134
  • [5] Long-term outcomes of Sleeping Beauty generated CD19-specific CAR T-cell therapy for relapsed-refractory B-cell lymphomas
    Srour, S. A.
    Singh, H.
    McCarty, J.
    de Groot, E.
    Huls, H.
    Rondon, G.
    Qazilbash, M.
    Ciurea, S.
    Bardelli, G.
    Buck, J.
    Alousi, A.
    Nieto, Y.
    Rezvani, K.
    Marin, D.
    Popat, U.
    Hosing, C.
    Shpall, E. J.
    Wierda, W. G.
    Kantarjian, H.
    Champlin, R. E.
    Cooper, L. J.
    Kebriaei, P.
    BLOOD, 2020, 135 (11) : 862 - 865
  • [6] CAR T-cell therapy for B-cell lymphomas: outcomes and resistance mechanisms
    Kearl, Tyce J.
    Furqan, Fateeha
    Shah, Nirav N.
    CANCER AND METASTASIS REVIEWS, 2025, 44 (01)
  • [7] Efficacy and safety of CD19-specific CAR T cell-based therapy in B-cell acute lymphoblastic leukemia patients
    Qi, Yuekun
    Zhao, Mingfeng
    Hu, Yongxian
    Wang, Ying
    Li, Ping
    Cao, Jiang
    Shi, Ming
    Tan, Jiaqi
    Zhang, Meng
    Xiao, Xia
    Xia, Jieyun
    Ma, Sha
    Qiao, Jianlin
    Yan, Zhiling
    Li, Hujun
    Pan, Bin
    Sang, Wei
    Li, Depeng
    Li, Zhenyu
    Zhou, Jianfeng
    Huang, He
    Liang, Aibin
    Zheng, Junnian
    Xu, Kailin
    BLOOD, 2022, 139 (23) : 3376 - 3386
  • [8] Acute kidney injury following treatment with CD19-specific CAR T-cell therapy in children, adolescent, and young adult patients with B-cell acute lymphoblastic leukemia
    Petgrave, Yonique
    Selukar, Subodh
    Epperly, Rebecca
    Naik, Swati
    Santos, Noel DeLos
    Triplett, Brandon M.
    Gottschalk, Stephen
    Bissler, John
    Talleur, Aimee C.
    PEDIATRIC NEPHROLOGY, 2024, 39 (08) : 2495 - 2503
  • [9] Predictors of Response to CD19-Specific CAR T Cell Therapy
    Melenhorst, Jan J.
    Fraietta, Joseph A.
    Lacey, Simon F.
    Orlando, Elena J.
    Ambrose, David E.
    Hwang, Wei-Ting
    Wilcox, Nicholas
    Bedoya, Felipe
    Dorfmeier, Corin
    Chen, Fang
    Parakandi, Harit
    Gupta, Minnal
    Pequignot, Edward
    Johnson, F. Brad
    Kulikovskaya, Irina
    Liu, Li
    Lundh, Stefan
    Wang, Yan
    Xu, Jun
    Young, Regina M.
    Levine, Bruce L.
    Frey, Noelle V.
    Siegel, Donald L.
    Huang, Alexander C.
    Wherry, E. John
    Khassim, Sadik H.
    Pruteanu-Malinici, Iulian
    Brogdon, Jennifer L.
    Bitter, Hans
    Porter, David L.
    June, Carl H.
    MOLECULAR THERAPY, 2017, 25 (05) : 238 - 238
  • [10] Predicting Outcomes following Anti-CD19 CAR T Cell Therapy in Aggressive B Cell Lymphomas
    Ho, Carrie
    Svoboda, Jakub
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (03): : 195 - 196
12345